Close Menu

NEW YORK (360Dx) – The global crisis of antibiotic resistance has tended to focus on patients in hospitals, but a low-cost immunoassay that could potentially help reduce the use of antibiotics for upper respiratory tract infections should soon be available in doctors' offices where most antibiotics are prescribed, according to test developer RPS Diagnostics.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.